FIA
HZNP

FNY Investment Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

FNY Investment Advisers’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-144,340
Closed -$16.7M – 853
2023
Q3 		$16.7M Buy
144,340
+99,945
+225% +$10.7M 9.93% 2
2023
Q2 		$4.57M Sell
44,395
-14,477
-25% -$1.53M 5.79% 2
2023
Q1 		$6.42M Buy
58,872
+56,872
+2,844% +$6.29M 7.35% 2
2022
Q4 		$227K Buy
+2,000
New +$166K 0.32% 72
2019
Q3 		– Sell
-3,350
Closed -$80K – 1333
2019
Q2 		$80K Buy
+3,350
New +$85K 0.02% 299
2019
Q1 		– Sell
-527
Closed -$10K – 1078
2018
Q4 		$10K Buy
+527
New +$10.3K ﹤0.01% 468

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FNY Investment Advisers's HZNP Position: Q4 2023 in Review

FNY Investment Advisers sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 144,340 shares — an estimated $16.7M sold.

FNY Investment Advisers first reported a position in HZNP in Q4 2018 and held it in 6 quarters. The position peaked at $16.7M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • FNY Investment Advisers reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • FNY Investment Advisers sold 144,340 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $16.7M.
  • FNY Investment Advisers first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 6 quarters.
  • FNY Investment Advisers's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $16.7M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on FNY Investment Advisers's 13F filing for Q4 2023, filed 12 Jan 2024.